Almirall Advances 2026 R&D Pipeline, Forecasts €800 Million in Biologics Sales
Written by Emily J. Thompson, Senior Investment Analyst
Source: Yahoo Finance
- Pipeline Expansion: Almirall plans to initiate three new clinical studies in 2026 targeting difficult-to-treat skin diseases, which is expected to significantly enhance the company's market position in medical dermatology.
- Sales Growth Outlook: The company anticipates achieving double-digit net sales growth by 2030, with peak sales of approximately €800 million for its biologics Ebglyss® and Ilumetri®, further solidifying its market leadership.
- Clinical Research Progress: The ongoing three PoC/Phase II clinical studies focus on innovative therapies for various skin diseases, expected to provide more effective treatment options for patients and address unmet medical needs.
- Financial Robustness: Almirall's sustained growth and profitability enable significant investments in R&D, with a projected EBITDA margin of 25% by 2028, supporting its long-term strategic development.
Analyst Views on ALM
Wall Street analysts forecast ALM stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ALM is 11.96 USD with a low forecast of 11.96 USD and a high forecast of 11.96 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Analyst Rating
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 9.000
Low
11.96
Averages
11.96
High
11.96
Current: 9.000
Low
11.96
Averages
11.96
High
11.96
About ALM
Almonty Industries Inc. is a diversified and global producer of tungsten concentrate. The Company is engaged in mining, processing and shipping tungsten concentrate from its Panasqueira Mine in Portugal. It also has a significant molybdenum resource on a separate property adjacent to the tungsten orebody at the Sangdong Mine. Its additional development projects include the Valtreixal Project in northwestern Spain and Los Santos Mine in western Spain. The Panasqueira Mine is located in Covilha, Castelo Branco, Portugal. The Sangdong Mine is located at Sangdong in the south-eastern Korean Peninsula, approximately 170 km east-southeast of Seoul, South Korea. The Valtreixal Mine is a potential open pit operation, and is located in the northwest part of the Zamora province, in the Castilla de Leon region of Spain. It also operates Woulfe, whose properties are located in Gangwon Province, Republic of Korea, and whose operations relate primarily to the development of the Sangdong Project.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
